Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Frost JN. et al, (2021), Med (N Y), 2, 164 - 179.e12

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Tan TK. et al, (2021), Nat Commun, 12

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Huo J. et al, (2020), Nat Struct Mol Biol, 27

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Rahikainen R. et al, (2020), Angewandte Chemie

Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.

Thakur N. et al, (2020), J Gen Virol

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.

Huo J. et al, (2020), Cell Host Microbe, 28

Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation.

Howarth M. et al, (2020), Angew Chem Int Ed Engl

Lung-targeting lentiviral vector for passive immunisation against influenza.

Tan TK. et al, (2020), Thorax

Lung-targeting lentiviral vector for passive immunisation against influenza

TAN TK. et al, (2020), Thorax

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.

Zhou D. et al, (2020), Nat Struct Mol Biol

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Huo J. et al, (2020), Nat Struct Mol Biol

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.

Huo J. et al, (2020), Cell Host Microbe

Lung targeting lentiviral vector for passive immunisation against influenza

TAN T. et al, (2020)

Lentiviral-Mediated Expression of Monoclonal Antibodies in the Lung to Protect Against Influenza

Du Y. et al, (2020), MOLECULAR THERAPY, 28, 60 - 60

An improved method for the rescue of recombinant Newcastle disease virus.

Cheow P-S. et al, (2020), Biotechniques, 68, 96 - 100

Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.

Rijal P. et al, (2020), J Virol, 94

cGAMP loading enhances the immunogenicity of VLP vaccines

Chauveau L. et al, (2020)

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.

Miao X. et al, (2020), MAbs, 12

Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases

De Caneva A. et al, (2018), HUMAN GENE THERAPY, 29, A115 - A115

Use of Pseudotyped, Replication-Deficient Influenza to Facilitate Testing of Gene Delivery Strategies for Treatment of Highly Infectious Diseases

Tan TK. et al, (2018), MOLECULAR THERAPY, 26, 242 - 243

Load More

Include forthcoming?